RP11-366L20.2, also known as HMGA2-AS1, has been recognized as an oncogene in pancreatic cancer (Ros et al., 2019) and osteosarcoma (Rothzerg et al., 2021). This evidence concerns the gene HMGA2 and osteosarcoma.